In this regard, the in vitro and in vivo studies indicate that the expression level of MYSM1 in primary tumor tissues is lower than that in adjacent normal tissues and is positively correlated with the OS of CRC patients, demonstrating the negative regulatory interaction between MYSM1 and CRC. This evidence concerns the gene MYSM1 and neoplasm.